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Viperin is an interferon-inducible protein that inhibits the replication of a variety of viruses by apparently
diverse mechanisms. In some circumstances, it also plays a role in intracellular signaling pathways.
Its expression in mitochondria, revealed by infection with human cytomegalovirus, also affects cellular
metabolic pathways. We review here the current status of our understanding of this unusual molecule.Introduction
The first line of defense against viral infection is the interferon
(IFN) response, which triggers the induction of a broad array
of antiviral proteins. Although some IFN-inducible proteins, for
example protein kinase R (PKR), the GTPase Mx1 (myxovirus
resistance 1), ribonuclease L (RNaseL), ISG15 (IFN-stimulated
protein of 15 kDa), and IFIT (IFN-induced proteins with tetratri-
copeptide repeats), have been functionally well characterized
as antiviral effectors (Daffis et al., 2010; Pichlmair et al., 2011;
Sadler and Williams, 2008), the functions of most IFN-inducible
proteins remain unexplored. Viperin (virus inhibitory protein,
endoplasmic reticulum-associated, interferon-inducible) is an
IFN-inducible protein that has recently received increasing
attention. It appears to have a number of functions, from being
an antiviral protein to modulating signaling events. Here, we
review these developments and attempt to provide a coherent
view of the properties of this unusual protein.
Characterization of Viperin
Viperin was identified as the product of an IFN-g-inducible gene
while analyzing the IFN-g response of human macrophages
(Chin and Cresswell, 2001). It is identical to cig5 (cytomegalo-
virus-inducible gene 5), which was isolated by differential display
analysis of primary fibroblasts infected with human cytomegalo-
virus (HCMV) (Zhu et al., 1997). Viperin is highly conserved in
evolution. A homolog called BEST5 (bone-expressed sequence
tag 5) was described as an IFN-inducible gene expressed during
rat osteoblast differentiation, and another called vig-1 (viral
hemorrhagic septicemia virus [VHSV]-induced gene 1) was
induced in rainbow trout leukocytes infected with VHSV, a fish
rhabdovirus. It has since been cloned from species ranging
from the mouse to a variety of other fish. A number of experi-
ments involving either overexpression of viperin or its knock-
down by short inhibitory RNAs in cell lines have indicated that
the protein possesses antiviral activity against a variety of RNA
and DNA viruses (see below).
Human viperin is composed of 361 amino acids with a molec-
ular mass of approximately 42 kDa. It is composed of three
distinct domains, an N-terminal domain, with length and se-
quence variability between species, a conserved central domain
that contains three cysteine residues organized in a CxxxCxxC534 Cell Host & Microbe 10, December 15, 2011 ª2011 Elsevier Inc.motif, and a C-terminal domain that is also highly conserved
between species (Figure 1). The N-terminal domain contains
an amphipathic a helix. This sequence may also constitute
a leucine zipper, but no zipper-like function, e.g., homodimeriza-
tion, has been ascribed to it. Amphipathic a helices are known
to bind membranes and induce membrane curvature (McMahon
and Gallop, 2005), and the N-terminal a helix is responsible for
viperin association with the cytosolic face of the endoplasmic
reticulum (ER) and also with lipid droplets (Hinson and Cress-
well, 2009a, 2009b). The interaction of viperin with the former
induces structural changes known as crystalloid ER, with
closely stacked ER leaflets formed by viperin oligomerization
at the cytosolic surface. The amphipathic a helix is not neces-
sary for viperin oligomerization and does not induce crystalloid
ER when attached to the monomeric fluorescent reporter
protein dsRed (Hinson and Cresswell, 2009b). The central
domain (residues 71–182 of human viperin) shows significant
homology with the MoA/PQQIII motif present in the ‘‘Radical
SAM’’ family of enzymes that use S-adenosylmethionine as a
cofactor, in which the CxxxCxxC motif is responsible for binding
iron-sulfur clusters. Thus, viperin is also known as RSAD2
(radical SAM domain-containing 2). Recently, it has been shown
that viperin can indeed bind Fe-S clusters (Duschene and Bro-
derick, 2010; Shaveta et al., 2010). Radical SAM enzymes
generally use the associated Fe-S cluster to generate a highly
oxidizing deoxyadenosyl radical to mediate a variety of reac-
tions. Although no specific enzyme activity has been ascribed
to viperin, the Fe-S binding motif is essential for its functional
activities in hepatitis C virus (HCV) and HCMV infection (Jiang
et al., 2008; Seo et al., 2011). The role of the conserved
C-terminal domain is unknown, but it might be involved in
protein-protein interactions and/or substrate recognition
required for mediating an enzyme activity. Consistent with
this, an aromatic amino acid residue at the C terminus of viperin
is required for its antiviral activity against HCV (Jiang et al.,
2008).
Regulation of Viperin Expression
Viperin is induced in a variety of cell types by type I (a and b), II
(g), and III (l) IFNs, by double-stranded (ds) B-form DNA, the
dsRNA analog poly I:C, lipopolysaccharide (LPS), and infection
Figure 1. Viperin Is Evolutionarily Highly
Conserved and Contains an N-Terminal
Amphipathic a Helix and Binds Fe-S Clusters
(A) The sequences for human, mouse, rat, and fish viperins
are shown, and conserved amino acid residues are
shaded in blue. The amphipathic a helix, shared by the
mammalian species, extends from residues 9–42. The
CxxxCxxC motif, responsible for coordinating the binding
of Fe4-S4 clusters, is embedded in a conserved region
extending from residues 71–182 that identifies viperin as
a member of the MoaA/PDQQIII family of radical SAM
proteins.
(B) Schematic diagram of viperin’s known domains. The
N-terminal domain is required for its localization to the
cytosolic face of the ER and lipid droplets. The central
domain which contains an Fe-S cluster binding motif
(CxxxCxxC) is essential for its functional activities in
hepatitis C virus (HCV) and human cytomegalovirus
(HCMV) infection. The C-terminal domain (residues 183–
361) is highly conserved but no functions have yet been
ascribed to it.
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expression in primary macrophages, IFN-a and IFN-b are more
effective in inducing its expression in the majority of cell types.
Viperin induction by poly I:C, LPS, dsDNA, and many viruses,
for example Sendai virus, Sindbis virus, and Pseudorabies virus
(PrV), is mediated by the classical IFN-stimulated gene (ISG)
induction pathways (Bowie and Unterholzner, 2008). IFN-
b synthesis is induced by interferon regulatory factors IRF3
and IRF7, which are activated by pattern recognition receptors
(PRRs), such as the Toll-like receptors TLR3 and TLR4, the
cytosolic retinoic acid inducible gene I (RIG-I)-like receptors
(RLRs), and cytosolic DNA sensor(s). The secreted IFN-b binds
to the type I IFN receptor (IFNR) on the cell surface in an auto-
crine/paracrine manner. This induces the formation of the
IFN-stimulated gene factor 3 (ISGF3) complex, which binds to
the viperin promoter and induces its expression (Figure 2).Cell Host & MicrobeSome viruses, such as HCMV and vesicular
stomatitis virus (VSV), directly induce viperin
independently of IFN production (Boehme
et al., 2004; Boudinot et al., 2000; Chin and
Cresswell, 2001; Zhu et al., 1997). In the former
case, this may be mediated by the HCMV
membrane glycoprotein, glycoprotein B (gB)
(Boehme et al., 2004). IFN-independent viperin
induction is directly regulated by IRF1 or IRF3
(DeFilippis et al., 2006; Stirnweiss et al., 2010).
It is known that IRF3 is able to discriminate
between different IFN-stimulated responsive
element (ISRE)-containing genes that directly
respond to virus infection (Grandvaux et al.,
2002). Both human and mouse viperin
promoters have two ISREs that are directly
responsive. A recent study has shown that
the IFN-independent viperin induction by VSV
appears to use IRFs activated by the mito-
chondrial anti viral signaling protein (MAVS),
in this case localized to peroxisomes rather
than mitochondria. Upon viral infection, peroxi-
somal MAVS induces rapid and transientIFN-independent viperin expression, whereas mitochondrial
MAVS activates IFN-mediated viperin expression with delayed
kinetics (Dixit et al., 2010). The IFN-mediated viperin gene
expression is regulated by ISGF3, and the IFN-independent
viperin gene expression is regulated by IRF1 and IRF3, as
described above. The latter also play a direct role in promoting
the peroxisomal MAVS signaling pathway.
Antiviral Functions of Viperin
Viperin has been reported to inhibit a broad spectrum of DNA
and RNA viruses, including herpesviruses (HCMV), flaviviruses
(HCV, West Nile virus [WNV], and Dengue virus), an alphavirus
(Sindbis virus), an orthomyxovirus (Influenza A virus), a para-
myxovirus (Sendai virus), a rhabdovirus (VSV), and a retrovirus
(HIV-1) (Chin and Cresswell, 2001; Jiang et al., 2008, 2010; Riv-
ieccio et al., 2006; Stirnweiss et al., 2010; Wang et al., 2007;10, December 15, 2011 ª2011 Elsevier Inc. 535
Figure 3. The Effects of Viperin Expression on Cellular Processes
Viperin association with the cytosolic face of the ER reduces the secretion rate
of soluble molecules, a function ascribed to the N-terminal amphipathic
a helix. The a helix also can target viperin to lipid droplets, where an activity
dependent on Fe-S cluster bindingmay affect the replication of viruses such as
HCV. Viperin expression also affects lipid raft formation, reducing membrane
fluidity and inhibiting the budding of influenza A virus. This effect depends on
viperin interaction with the enzyme FPPS.
Figure 2. Regulation of Viperin Expression
Viperin induction is mediated by both the classical IFN-stimulated gene
induction pathway and the IFN-independent pathway. The IFN-mediated
viperin gene expression is regulated by ISGF3 (left), while IFN-independent
viperin gene expression is regulated by IRF1 and IRF3 (right), which can be
activated by viral factors or by the peroxisomal MAVS signaling pathway.
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of cell lines, using stable or transient pre-expression (or overex-
pression) of viperin to inhibit viral replication, or knockdown of
viperin by RNA interference (RNAi) to detect a reversal of
viperin-mediated inhibition of viral replication. The sheer range
of affected viruses, which use different routes of infection and
mechanisms of replication, has made it very difficult to identify
a unified mechanism that explains all the data.
Some in vivo data that argue for an antiviral function were
provided by studies of Sindbis virus (Zhang et al., 2007). Subcu-
taneous inoculation of neonatal mice with RNA encoding Sindbis
virus that also encoded viperin resulted in a significant attenua-
tion of virulence compared to a similar Sindbis RNA encoding
a control protein. Overexpression of viperin in a stable tetracy-
cline-inducible murine fibroblast culture system also resulted in
a modest inhibition of Sindbis virus replication. More recently,
Szretter et al. have found that mice lacking the viperin gene are
significantly more susceptible to WNV infection, and that this
correlates with a modest increase in WNV replication in
viperin/ macrophages and dendritic cells in vitro (Szretter
et al., 2011). Other investigators showed that knockdown of
viperin with RNAi partially reverses poly I:C-induced inhibition
of HIV-1 replication in astrocytes (Rivieccio et al., 2006), sug-
gesting that it has a possible role in the innate response against
infection in the central nervous system. In all of these cases, the
underlying molecular mechanism of viperin action remains
unknown.
Pre-expression of viperin in human fibroblasts significantly
inhibits the replication of HCMV, reducing expression of several
HCMV structural proteins, such as gB, pp65, and pp28, that
are known to be indispensable for HCMV maturation and/or
assembly (Chin and Cresswell, 2001). This suggests that viperin
may exert its antiviral effect by inhibiting the synthesis or function
of virally encoded components critical for productive infection.536 Cell Host & Microbe 10, December 15, 2011 ª2011 Elsevier Inc.Pre-expressed viperin colocalized with gB in the ER during the
attenuated viral infection, while viperin induced by HCMV infec-
tion moved together with gB from the ER, first to the Golgi and
eventually to the virus assembly compartment (Chin and Cress-
well, 2001). It was suggested that this reflected a viral evasion
mechanism, i.e., its antiviral effects required viperin to be asso-
ciated with the ER. Viperin expression has been shown to slow
the rate of transport of soluble proteins from the ER (Hinson
and Cresswell, 2009b), suggesting that it might interfere with
transport of critical viral components. However, the transport
rate of membrane-associated glycoproteins was not affected
by viperin, making unlikely the otherwise attractive explanation
that reduced transport of viral membrane proteins, including
gB, to the assembly compartment affects HCMV assembly.
Viperin expression in HeLa cells using a tetracycline-inducible
system was found to inhibit budding and release of influenza
A virus by disrupting lipid raft microdomains on the plasma
membrane (Figure 3). Viperin was found to bind and inhibit
farnesyl diphosphate synthase (FPPS), an enzyme involved in
the synthesis of multiple isoprenoid-derived lipids, including
cholesterol. Overexpression of FPPS reversed the inhibition of
virus production and restored normal membrane fluidity (Wang
et al., 2007). The data suggest that viperin may inhibit viruses
that use lipid rafts for their entry or for budding and release.
However, the most appealing idea, that the inhibition of FPPS
activity reduced cholesterol synthesis to affect lipid raft forma-
tion, could not be substantiated, and the precise mechanism
by which viperin affects lipid raft formation and membrane
fluidity remains unresolved.
Expression of full-length viperin, but not a mutant form lacking
the N-terminal amphipathic a helix, was found to decrease
HCV replication (Jiang et al., 2008). The N-terminal amphipathic
a helix of viperin is essential for its capacity to localize to lipid
droplets, a site of HCV replication. It is therefore tempting to
suggest that, for HCV, the antiviral mechanism requires lipid
droplet association. The HCV nonstructural 5A protein (NS5A)
Figure 4. Viperin Modulates Cellular Metabolism during HCMV
Infection
Viperin is relocalized from the ER to mitochondria by binding to the HCMV
vMIA protein. Viperin interacts with trifunctional protein (TFP), responsible for
fatty acid b oxidation, at the inner membrane as well as the outer membrane of
mitochondria, reducing total cellular ATP generation. A major consequence is
that the actin cytoskeleton is disrupted, which enhances viral infection.
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for its lipid droplet association. Dengue virus also replicates on
lipid droplets, suggesting that this may be a characteristic site
for flavivirus replication, and the effects of viperin on HCV,
Dengue virus, and WNV may reflect this common link. This
remains speculation until the precise mechanism of viperin
action is clarified, although the fact that the Fe-S cluster motif
is also required for the inhibitory effect on all three flaviviruses
suggests that a radical SAM activity focused on a lipid droplet
might be involved (Jiang et al., 2008; Jiang et al., 2010).
Roles for Viperin in Signaling and the Immune Response
Recently, it has been suggested that viperin serves as amediator
in signaling pathways, and again lipid droplet association
appears to play a key role. A comparison of viperin-negative
and -positive plasmacytoid dendritic cells (pDCs) suggested
that viperin mediates TLR7- and TLR9-induced production of
type I IFN by this cell type, which has a critically important role
as the major producer of type I IFNs in viral infections (Saitoh
et al., 2011). Viperin was found to recruit the signaling mediators
IRAK1 and TRAF6 to lipid droplets in pDCs, apparently by direct
interaction. This facilitates ubiquitination of IRAK1, which in turn
induces the nuclear translocation of IRF7 and stimulates type I
IFN expression. While a direct connection between the two
scenarios is not obvious, a signaling function of viperin may
underlie the impaired Th2 cell development observed in viperin
knockout mice (Qiu et al., 2009). In vitro experiments indicated
that viperin facilitates T cell receptor-mediated GATA-3 activa-
tion and Th2 cell development by modulating NF-kB and AP-1
activities.
A Virus that Eliminates Viperin and One that Co-opts It
Like the adaptive immune system, IFN-inducible proteins
commonly force the evolution of viral strategies to counteract
their effects, and viperin is no exception. Japanese Encephalitis
Virus (JEV) infection induces viperin expression but simulta-Ceneously causes its proteasome-dependent degradation. Over-
expression of viperin or knockdown of viperin expression by
RNAi does not substantially influence JEV replication in vitro,
but the addition of the proteasome inhibitor MG132 to JEV-in-
fected cells sustains high levels of viperin expression and reveals
an antiviral effect (Chan et al., 2008). The mechanism by which
viperin degradation is induced is currently unknown.
As described earlier, viperin that is induced by HCMV infection
moves from its normal location at the cytosolic face of the ER
to the Golgi and then the viral assembly compartment (Chin
and Cresswell, 2001). This was also interpreted as an evasion
strategy, with the assumption that the antiviral effect requires
viperin to reside at the ER. Although we have no reason to
suppose that lipid droplets are important in the HCMV infection
process, the currently unknown mechanism used by the virus
to divert viperin would presumably also remove it from lipid
droplets, which are ER-derived organelles. However, the story
is more complex than it initially appeared. We recently found
that, before viperin is transferred to the Golgi and the HCMV
assembly compartment, it is transported to mitochondria, where
it has a profound effect on cellular metabolism (Figure 4) (Seo
et al., 2011). The redistribution of viperin to mitochondria is
mediated by its interaction with an HCMV-encoded protein,
the viral mitochondrial inhibitor of apoptosis (vMIA), which is
targeted to mitochondria by an N-terminal mitochondrial locali-
zation signal. Viperin then interacts with the b subunit (HADHB)
of the mitochondrial trifunctional protein (TFP) that catalyzes
the final steps of fatty acid b oxidation to generate adenosine
triphosphate (ATP). This interaction inhibits TFP activity and
therefore reduces cellular ATP generation. Amajor consequence
is that the actin cytoskeleton is disrupted, which enhances the
infection. That these effects are not a function of vMIA itself
was demonstrated by replacing the N-terminal amphipathic
a helix of viperin with a mitochondrial targeting sequence, either
from vMIA or from the mammalian mitochondrial protein Tom70.
Directly targeted viperin had the same effects on ATP generation
and the actin cytoskeleton with no requirement for vMIA. The
Fe-S binding motif of the radical SAM domain was necessary
for the effects, although it was not required for the interaction
with TFP (Seo et al., 2011).
How Does Viperin Work?
Four host proteins have been proposed to interact with viperin:
FPPS, TFP, IRAK1, and TRAF6. The first two are involved in
metabolism, and the last two in signaling. Functions have been
ascribed to all of these interactions, but it is surprising that
viperin is so promiscuous in its choice of binding partners. It is
the product of an ancient gene, and acquisition of multiple func-
tions by a protein over evolutionary time may not be unreason-
able, but it does give one pause and certainly suggests that
the ultimate answers to the function of viperin will be far from
simple.
Studies of the protective functions of viperin have to date
focused on its effects on viral infections. However, viperin induc-
tion by nonviral microbial products such as LPS suggests that
viperin might be involved in host responses to bacteria or proto-
zoan parasites. IFN-g, most commonly associated with antibac-
terial responses, stimulates viperin expression in macrophages
in vitro and the high expression of viperin in macrophages andll Host & Microbe 10, December 15, 2011 ª2011 Elsevier Inc. 537
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with LPS (Hinson et al., 2010). Why this is so remains unclear, but
the phagocytic and bacteriocidal capacities of these cell types
are well established.
Localization to the ER and lipid droplets by the N-terminal
amphipathic a helix seems likely to be functionally important.
Lipid droplet association may be particularly important for
suppression of flaviviruses, as described above. The amphi-
pathic a helix itself has inhibitory effects on the transport of
soluble molecules from the ER, perhaps because an increase
in membrane curvature reduces the inclusion of soluble cargo
in transport vesicles, but it remains unclear what intact viperin
does at this site. The variety of experiments suggesting a role
for Fe-S binding by mutation of the CxxxCxxC motif indicates
that a free radical-based mechanism is likely to underlie most
of the observed effects of viperin. The Radical SAM family of
enzymes catalyzes a diverse range of reactions, and viperin
could, for example, activate glycyl or alkane radicals that modify
cellular metabolites or proteins. However, while recombinant
viperin can bind Fe-S clusters in vitro, we do not find Fe associ-
ation with a nonmembrane-associated viperin construct that
lacks the amphipathic a helix when it is expressed in either
insect cells or yeast (E. Hinson and P.C., unpublished data). It
may be that Fe-S cluster binding is regulated in a manner that
requires membrane association. It may even require that viperin
interacts with or enters mitochondria, which are the intracellular
source of Fe-S clusters (Lill and Mu¨hlenhoff, 2008). The
N-terminal sequence of mouse and particularly human viperin
has a high probability of being a mitochondrial targeting
sequence according to the MitoProt program that identifies
such sequences. However, a construct that incorporates this
sequence N-terminal to the dsRed protein does not localize to
mitochondria (Hinson and Cresswell, 2009a, 2009b). This
suggests that any interaction with mitochondria would require
either a regulated posttranslational modification or an interac-
tion with another host protein, analogous to the vMIA interaction
seen in HCMV infection.
Viruses rely on the metabolism of the infected cells to provide
the energy and building blocks required for viral replication, and
they can modify the metabolic state of the infected cell. For
example, HCMV infection causes dramatic alterations in inter-
mediary metabolism, similar to those found in tumor cells. The
infection upregulates flux through central carbon metabolism,
including glycolysis, and increases efflux to fatty acid biosyn-
thesis, a function presumably selected for because the virus
requires membrane for the viral envelope (Munger et al., 2008).
Similarly, HCV increases host catabolic and biosynthetic activi-
ties early in infection, while the virus induces a compensatory
metabolic shift to maintain energy homeostasis and cell viability
during the progression of infection. Interestingly, the HADHB
subunit of TFP was predicted to be one of key regulators of
HCV-associated metabolic reprogramming (Diamond et al.,
2010), raising the possibility that the viperin interaction with
TFP may be involved in this case too.
The effects on cellular metabolism of viperin targeted to
mitochondria almost certainly reflect a normal function of
IFN-induced viperin. It seems highly unlikely that HCMV
‘‘invented’’ the process; it is much more probable that the virus
has co-opted, even exaggerated, a natural function. The inhibi-538 Cell Host & Microbe 10, December 15, 2011 ª2011 Elsevier Inc.tion of fatty acid b oxidation induced by mitochondrial viperin
and the resulting reduction of cellular ATP levels may be inhib-
itory for viruses other than HCMV, and it will be interesting to
examine cells infected with different viruses to determine if
a fraction of the induced viperin is targeted to mitochondria.
Viperin localization to mitochondria might be also related to
mitochondrial dynamics. Mitochondrial fusion and fragmenta-
tion can regulate mitochondrial antiviral signaling, including
MAVS-mediated activation of the RLR pathway (Castanier
et al., 2010; Yasukawa et al., 2009). In addition, it has been
suggested that the HCMV protein vMIA mediates mitochondrial
fragmentation in a strategy to interfere with antiviral signaling
pathways (Castanier et al., 2010). Studies to assess the rela-
tionship between viperin and mitochondrial dynamics may
provide additional insights into the function of viperin during
viral infections.
Concluding Remarks
The published data indicate that viperin is an important antiviral
molecule, and yet its precise mechanism of action remains
mysterious. Identification of an activity associated with its
membership in the radical SAM family of enzymes would be
a great asset in understanding its function. While the ER and lipid
droplet associations are clear, mitochondrial localization has so
far been observed only in the case of HCMV infection, although it
seems likely that viperin must have a mitochondrial function is
other circumstances. Mitochondria and the ER are commonly
connected in cells by so-called mitochondria-associated
membranes (MAM) in a manner that facilitates calcium and
phospholipid exchange. It has recently been suggested that
MAM is an important site for regulating RIG-I and MAVS
signaling (Horner et al., 2011) and it may also be important for
viperin-mediated activities.
Viperin knockout mice exist but have failed to show signifi-
cantly enhanced susceptibility to viral infection until the very
recent observation of enhanced WNV infection. The lack of an
effect with a particular virus may simply reflect the range of
antiviral effectors in addition to viperin that are stimulated by
IFNs. The mice have indicated a role for viperin in modulating
the T cell response, and cells derived from them have been
useful in unraveling the metabolic effects of viperin and its role
in type IFN induction in pDCs. However, much more work is
required to clarify the multiple functions associated with this
enigmatic molecule, which may be more aptly named than orig-
inally supposed.
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